Kowalsky Matthew Paul
Insider CIK 1705824 · ENTA Chief Legal Officer · PRTO VP, Legal and Secretary · SGTX CHIEF OF STAFF AND CLO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2026-02-12 | 2026-02-13 | 1,902 | $14.25 | $27.1K | 3,591 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2026-02-12 | 2026-02-13 | 1,318 | — | $0 | 1,318 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2026-02-12 | 2026-02-13 | 4,175 | — | $0 | 5,493 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2025-11-25 | 2025-11-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2024-11-27 | 2024-11-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2024-04-29 | 2024-05-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 12,690 | $0.75 | $9.5K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer | 2023-08-11 | 2023-08-11 | 1,925 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2023-02-28 | 2023-03-01 | 165,000 | — | $0 | 165,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2019-01-18 | 2019-01-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award | 2018-12-31 | 2019-01-03 | 2,448 | $1.93 | $4.7K | 29,479 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award | 2018-06-29 | 2018-07-03 | 10,000 | $1.62 | $16.2K | 27,031 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2018-01-17 | 2018-01-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award | 2017-12-29 | 2018-01-03 | 3,934 | $1.30 | $5.1K | 17,031 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award | 2017-06-30 | 2017-07-05 | 10,000 | $1.30 | $13.0K | 13,097 | SEC↗ |